CEO increases shareholding in Meda Meda's CEO, Anders Lönner, has bought 666 322 shares in connection with the new share issue. His total shareholding now amounts to 4 664 254 shares, which is equivalent to a market value of about 200 MSEK based on today's share price. For more information, please contact: Anders Larnholt, Vice President Investor Relations, tel. +46 709 458 878 MEDA AB (publ) is a leading international specialty pharma company. The company specialises in marketing and pharmaceutical development in late clinical stage. Acquisitions and long-term partnerships are fundamental factors that drive the company's strategy. Meda is represented by its own organisations in about 40 countries. Meda's products are sold in 120 countries worldwide. The Meda share is listed under Large Cap on the OMX Nordic Stock Exchange. Find out more, visit www.meda.se.
CEO increases shareholding in Meda
| Source: Meda AB